Search - tctmd.com

Displaying 21 - 40 of 314

Sort: Relevancy | Date

Presentation TCT 2025

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

Presenter: Ulf Teichgräber

October 26, 2025

Presentation TCT 2025

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

Presenter: Osamu Iida

October 26, 2025

Presentation TCT 2025

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Presenter: Ramon L. Varcoe

October 26, 2025

Presentation TCT 2025

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

Presenter: Donald Cutlip

October 26, 2025

Presentation TCT 2025

One-Year Results of the SELUTION DeNovo Trial Comparing a Strategy of PCI with a Sirolimus-eluting Balloon and Provisional Stenting Versus Systematic DES Implantation to Treat DeNovo Coronary Lesions

Presenter: Christian M. Spaulding

October 26, 2025

Presentation TCT 2025

A Novel Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Technology Description and Clinical Results

Presenter: Lei Song

October 26, 2025

Presentation TCT 2025

TCT 202: Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: First Patient-Level Pooled Analysis Comprising Randomized IRONMAN-II Trial and Prospective IRONMAN-III Registry

Presenter: Lei Song

October 26, 2025

Presentation TCT 2025

TCT 1708: Kissing DCBs in NSTEMI: Sirolimus-Coated Balloon Use With Selution™ for ISR and Stent Thrombosis in a Bifurcation Lesion

Presenter: Davit Baghdasaryan

October 26, 2025

Presentation TCT 2025

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Presenter: Dierk Scheinert

October 26, 2025

Presentation TCT 2025

Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study

Presenter: Alexandre Abizaid

October 25, 2025

Presentation TCT 2025

Angiographic Performance Following PCI With a Sirolimus-Eluting Balloon in De Novo Coronary Artery Lesions: The GINGER Study

Presenter: Antonio Colombo

October 25, 2025

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

Magic Touch

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

Selution

Presenter: Simon Eccleshall

October 30, 2024

Presentation TCT 2024

Sirolimus- vs. Paclitaxel-Coated Balloons for the Treatment?of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 30, 2024

Presentation TCT 2024

TCT 506: Comparison of Healing Pattern Using Optical Coherence Tomography in Small vs Large Coronary Arteries After Sirolimus-eluting Stents Implantation

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

TCT 504: Comparison of Vessel Responses Following Combined Sirolimus-Eluting and Endothelial Progenitor Cell Stent and Ultra-Thin Sirolimus-Eluting Stent Implantation by Serial OCT and Coronary Angioscopy

Presenter: Atsushi Kikuchi

October 30, 2024

Presentation TCT 2024

Paclitaxel, Sirolimus, Biolimus: The Art of DCBs Selection

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

Advertisement

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

One-Year Results of the SELUTION DeNovo Trial Comparing a Strategy of PCI with a Sirolimus-eluting Balloon and Provisional Stenting Versus Systematic DES Implantation to Treat DeNovo Coronary Lesions

A Novel Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Technology Description and Clinical Results

TCT 202: Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: First Patient-Level Pooled Analysis Comprising Randomized IRONMAN-II Trial and Prospective IRONMAN-III Registry

TCT 1708: Kissing DCBs in NSTEMI: Sirolimus-Coated Balloon Use With Selution™ for ISR and Stent Thrombosis in a Bifurcation Lesion

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study

Angiographic Performance Following PCI With a Sirolimus-Eluting Balloon in De Novo Coronary Artery Lesions: The GINGER Study

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Magic Touch

Selution

Sirolimus- vs. Paclitaxel-Coated Balloons for the Treatment?of Coronary Artery Disease

TCT 506: Comparison of Healing Pattern Using Optical Coherence Tomography in Small vs Large Coronary Arteries After Sirolimus-eluting Stents Implantation

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

TCT 504: Comparison of Vessel Responses Following Combined Sirolimus-Eluting and Endothelial Progenitor Cell Stent and Ultra-Thin Sirolimus-Eluting Stent Implantation by Serial OCT and Coronary Angioscopy

Paclitaxel, Sirolimus, Biolimus: The Art of DCBs Selection

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content